Central Pacific Bank Trust Division Decreases Stake in Church & Dwight Co., Inc. (NYSE:CHD)

Central Pacific Bank Trust Division lowered its position in Church & Dwight Co., Inc. (NYSE:CHD) by 88.8% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 442 shares of the company’s stock after selling 3,506 shares during the period. Central Pacific Bank Trust Division’s holdings in Church & Dwight were worth $46,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Abacus Planning Group Inc. lifted its holdings in Church & Dwight by 10.7% in the 3rd quarter. Abacus Planning Group Inc. now owns 10,496 shares of the company’s stock valued at $1,099,000 after purchasing an additional 1,014 shares in the last quarter. Point72 DIFC Ltd purchased a new position in shares of Church & Dwight during the 2nd quarter worth $50,000. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of Church & Dwight during the 2nd quarter worth $33,000. Cim LLC raised its holdings in shares of Church & Dwight by 5.0% during the 2nd quarter. Cim LLC now owns 33,998 shares of the company’s stock worth $3,586,000 after acquiring an additional 1,610 shares during the period. Finally, Sanctuary Advisors LLC purchased a new position in shares of Church & Dwight during the 2nd quarter worth $2,480,000. Hedge funds and other institutional investors own 86.60% of the company’s stock.

Church & Dwight Price Performance

NYSE:CHD traded down $0.30 during trading hours on Friday, hitting $101.04. The company’s stock had a trading volume of 1,037,118 shares, compared to its average volume of 1,375,513. The business’s 50-day moving average is $102.35 and its two-hundred day moving average is $104.16. The company has a market capitalization of $24.71 billion, a PE ratio of 32.07, a PEG ratio of 3.82 and a beta of 0.54. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.98 and a current ratio of 1.53. Church & Dwight Co., Inc. has a 52-week low of $82.25 and a 52-week high of $110.31.

Church & Dwight (NYSE:CHD) last posted its earnings results on Friday, August 2nd. The company reported $0.93 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.09. The company had revenue of $1.51 billion for the quarter, compared to analyst estimates of $1.51 billion. Church & Dwight had a return on equity of 19.86% and a net margin of 13.38%. Church & Dwight’s revenue was up 3.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.92 earnings per share. As a group, research analysts anticipate that Church & Dwight Co., Inc. will post 3.43 EPS for the current fiscal year.

Church & Dwight Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 3rd. Shareholders of record on Thursday, August 15th were issued a $0.2838 dividend. This represents a $1.14 annualized dividend and a yield of 1.12%. The ex-dividend date was Thursday, August 15th. Church & Dwight’s dividend payout ratio (DPR) is 35.87%.

Insider Buying and Selling at Church & Dwight

In other Church & Dwight news, EVP Barry A. Bruno sold 59,328 shares of the company’s stock in a transaction on Monday, August 5th. The stock was sold at an average price of $99.37, for a total value of $5,895,423.36. Following the sale, the executive vice president now owns 4,319 shares of the company’s stock, valued at approximately $429,179.03. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 2.00% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

CHD has been the subject of several recent research reports. Argus lifted their price objective on Church & Dwight from $115.00 to $125.00 and gave the company a “buy” rating in a research note on Tuesday, June 11th. Piper Sandler began coverage on shares of Church & Dwight in a report on Tuesday, September 24th. They set an “overweight” rating and a $120.00 price target for the company. JPMorgan Chase & Co. reduced their price objective on shares of Church & Dwight from $101.00 to $97.00 and set an “underweight” rating on the stock in a report on Monday, August 5th. TD Cowen assumed coverage on Church & Dwight in a report on Tuesday, July 23rd. They issued a “buy” rating and a $116.00 target price on the stock. Finally, Evercore ISI dropped their target price on Church & Dwight from $110.00 to $101.00 and set an “in-line” rating on the stock in a report on Monday, August 5th. Three investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $107.25.

Church & Dwight Company Profile

Church & Dwight Co, Inc develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand.